Prot #CCP-020-301: An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/26/17 → 7/26/20

Funding

  • Medpace, Inc. (Prot #CCP-020-301 // Prot #CCP-020-301)
  • Castle Creek Pharmaceuticals LLC (Prot #CCP-020-301 // Prot #CCP-020-301)